Home » News & Resources » Press Releases
Fluidigm Press Releases

2014
  • October 2, 2014
    Fluidigm Redefines Single-Cell Whole Exome Sequencing
  • September 25, 2014
    Stanford Researchers use Single-Cell Mass Cytometry to Predict Recovery Time from Surgery
  • September 16, 2014
    Fluidigm’s New Juno™ System Shatters Barriers for SNP Genotyping
  • August 6, 2014
    UCSF/Fluidigm Paper Proves Shallow Sequencing of Related Single Cells Sufficient to Harvest Meaningful Biological Information
  • July 31, 2014
    Fluidigm Reports Q2 2014 Results - Strong Q2 2014 organic revenue growth of 32% year-over-year
  • July 31, 2014
    Fluidigm Announces Early Access Program for New Imaging Mass Cytometry Platform
  • July 23, 2014
    Fluidigm to Announce Q2 2014 Financial Results and Host Conference Call for Investors
  • June 30, 2014
    Single-Cell mRNA Sequencing Helps Reveal the Role of “Precocious” Dendritic Cells in Inflammatory Response
  • June 19, 2014
    Fluidigm Accelerates Single-Cell Science with the New C1™ Open App™ Program
  • June 3, 2014
    Fluidigm Ships FLEXsix™ Integrated Fluidic Circuits to Genotyping and Gene Expression Customers
  • May 6, 2014
    Fluidigm to Present at the Bank of America Merrill Lynch 2014 Healthcare Conference
  • May 5, 2014
    Fluidigm Reports Q1 2014 Results – Q1 2014 Organic Revenue Growth of 58% Year-Over-Year
  • April 23, 2014
    Fluidigm to Announce Q1 2014 Financial Results and Host Conference Call for Investors
  • February 26, 2014
    Fluidigm to Present at the Cowen and Company 34th Annual Health Care Conference
  • February 13, 2014
    Fluidigm Completes Acquisition of DVS Sciences
  • February 6, 2014
    Fluidigm Reports Strong Revenue for Q4 and the Full Year 2013 - Full Year 2013 Revenue Up 36%
  • January 31, 2014
    Fluidigm to Announce Q4/Full Year 2013 Financial Results and Host Conference Call for Investors
  • January 30, 2014
    Fluidigm Announces Pricing of $175 Million Convertible Senior Notes Offering
  • January 29, 2014
    Fluidigm and DVS Sciences Announce Agreement for Fluidigm to Acquire DVS Sciences – Creating a Single-Cell Technology Powerhouse
  • January 29, 2014
    Fluidigm Announces Proposed $175 Million Convertible Senior Notes Offering
  • January 14, 2014
    Fluidigm Announces Preliminary Fourth Quarter 2013 Revenue and Issues 2014 Revenue Guidance
  • January 8, 2014
    Fluidigm to Present at the 32nd Annual J.P. Morgan Healthcare Conference

2013

  • December 31, 2013
    Nature Selects “Single-Cell Sequencing” as the 2013 Method of the Year
  • December 24, 2013
    Fluidigm Launches Single-Cell DNA Sequencing Workflow to Study Somatic Mutations in Heterogenous Samples
  • November 27, 2013
    Fluidigm to Present at the 25th Annual Piper Jaffray Healthcare Conference
  • November 6, 2013
    Fluidigm to Present at the Credit Suisse 2013 Healthcare Conference
  • October 30, 2013
    Fluidigm Reports Financial Results For Third Quarter 2013. Strong Q3 2013 revenue growth of 43%
  • October 16, 2013
    Fluidigm to Announce Q3 2013 Financial Results and Host Conference Call for Investors
  • October 1, 2013
    Fluidigm and Nanostring Agree to Litigation Settlement
  • September 9, 2013
    Fluidigm C1 Single-Cell Auto Prep System Wins Prestigious IBO Design Award
  • August 1, 2013
    Fluidigm Reports Strong Q2 2013 Revenue Growth Of 35%
  • August 1, 2013
    Fluidigm Enables the Study of miRNA Master Regulators Down to the Single Cell Level
  • July 31, 2013
    Fluidigm and Olink Bioscience Bring a New Level of Protein Biomarker Discovery to the Life Science Research Market
  • July 22, 2013
    Fluidigm to Announce Q2 2013 Financial Results and Host Conference Call for Investors
  • May 9, 2013
    Saskatchewan Disease Control Laboratory Selects Fluidigm BioMark™ HD Platform to Track Infectious Agents
  • May 7, 2013
    Fluidigm to Present at the Bank Of America Merrill Lynch 2013 Health Care Conference
  • May 4, 2013
    DVS Sciences (now a Fluidigm company) announces new CyTOF® 2 Mass Cytometer
  • May 4, 2013
    DVS Sciences (now a Fluidigm company) launches new MaxPar® Panel kits to simplify high parameter experiments
  • May 1, 2013
    Fluidigm Reports Strong Q1 2013 Results
  • May 1, 2013
    Fluidigm to Develop and Supply a Custom High-throughput Prep System for HLA Typing
  • April, 24, 2013
    Fluidigm to Announce Q1 2013 Financial Results and Host Conference Call for Investors
  • April 12, 2013
    Singapore Single-Cell Research Centre Opens Door For Asian Biological Discoveries
  • February 26, 2013
    Fluidigm to Present at 33rd Annual Cowen Health Care Conference
  • February 12, 2013
    Fluidigm Reports Strong Q4 and Full Year 2012 Q4 Product Revenue Up 25%;
    Full Year Product Revenue Up 27%
  • February 7, 2013
    Fluidigm to Present at Leerink Swann 2013 Global Healthcare Conference
  • February 4, 2013
    Fluidigm to Announce Q4/Full Year 2012  Financial Results and Host Conference Call for Investors
  • January 14, 2013
    Gerhard Burbach Joins Fluidigm Board Of Directors
  • January 8, 2013
    Fluidigm C1™ Single-Cell Auto Prep System Wins a 2012 Good Design Award
  • January 2, 2013
    Fluidigm Completes C1™ Single-Cell Auto Prep System Early Access Program

2012

  • December 19, 2012
    Fluidigm Introduces mRNA Sequencing Application for the C1™ Single-Cell Auto Prep System
  • December 14, 2012
    Genome Institute of Singapore and Fluidigm Establish Asia's First Single-Cell Genomics Research Center
  • November 14, 2012
    Fluidigm, for the Second Year in a Row, Named One of the Fastest Growing Companies on Deloitte’s Fast 500™ List
  • November 7, 2012
    Fluidigm Files Lawsuit Against Nanostring’s Deceptive Marketing
    Fluidigm-NanoString Litigation FAQ
  • November 7, 2012
    Fluidigm Reports Financial Results for Third Quarter 2012
  • November 1, 2012
    Fluidigm Introduces Four New Integrated Fluidic Circuits for Production Genomics
  • October 31, 2012
    Fluidigm to Announce Q3 2012 Financial Results and Host Conference Call for Investors
  • October 25, 2012
    Fluidigm Sponsors, Exhibits and Presents at Roddenberry International Symposium on Cellular Reprogramming in San Francisco
  • September 25, 2012
    Fluidigm Joins AMDeC Vendor Partnership Program, Gaining Access to World-Class New York-Area Academic Research Institutions Through AMDeC F.I.R.S.T.™
  • August 21, 2012
    Fluidigm Announces Exercise of Underwriters’ Over-Allotment Option and Closing of $60 million Public Offering of Common Stock
  • August 16, 2012
    Fluidigm Prices $52.2 Million Public Offering of Common Stock
  • August 15, 2012
    Fluidigm Announces Proposed Public Offering of Common Stock
  • August 7, 2012
    Fluidigm Reports Financial Results For Second Quarter 2012
  • July 31, 2012
    Fluidigm to Announce Q2 2012 Financial Results and Host Conference Call for Investors
  • June 24, 2012
    DVS Sciences (now a Fluidigm company) and Cytobank announce partnership to analyze and manage high-parameter mass cytometry data
  • June 13, 2012
    Fluidigm Introduces the C1™ Single-Cell Auto Prep System to Researchers at ISSCR – Starts Early Access Program
  • May 10, 2012
    Fluidigm Reports Financial Results For First Quarter 2012
  • May 8, 2012
    Fluidigm and the Broad Institute Establish Single-Cell Genomics Research Center
  • May 7, 2012
    Fluidigm Announces Unrestricted Sales into Prenatal Health and Non-Invasive Prenatal Diagnostics Fields of Research
  • May 3, 2012
    Fluidigm Announces Timing for Release of First Quarter 2012 Financial Results
  • April 16, 2012
    Fluidigm China Opens Its Doors
  • April-12-2012
    Ambry Genetics Initiates Fluidigm-Based Genomic Research Services For Gene Expression, SNP Genotyping and Sample Prep for Targeted Sequencing
  • February 29, 2012
    Fluidigm to Present at Cowen and Company 32nd Annual Healthcare Conference
  • February 15, 2012
    Fluidigm Announces Date of its 2012 Annual Meeting of Stockholders and Deadline for Submitting Stockholder Proposals
  • February 14, 2012
    Fluidigm Reports Strong Year-End and Full Year Growth in 2011
  • February 13, 2012
    New Access Array™ Target-Specific Multiplexing Capability Allows Up to 480 Amplicons Per Sample for Targeted Resequencing
  • February 13, 2012 
    Fluidigm Introduces Access Array™ Barcode Library for Ion Torrent Personal Gemone Machine (PGM) Sequencer
  • February 8, 2012
    Fluidigm Announces Timing for Release of Fourth Quarter/Full Year 2011 Financial Results
  • January 31, 2012
    Fluidigm and AH Diagnostics Sign Distribution Deal for Scandinavia
  • January 16, 2012
    MOgene LC Brings Fluidigm Access Array Sample Prep Technology to its Customer Base
  • January 10, 2012
    Fluidigm to Participate in the 30th Annual J.P. Morgan Healthcare Conference
  • January 1, 2012
    CyTOF selected as one of Top 10 Innovations of 2011

2011

  • November 28, 2011
    Fluidigm to Participate in the 23rd Annual Piper Jaffray Healthcare Conference
  • November 8, 2011
    Fluidigm Reports strong growth for third quarter 2011
  • November 1, 2011
    Fluidigm Announces Timing for Release of Third Quarter 2011 Financial Results
  • October 19, 2011
    Fluidigm Named One of the Fastest Growing Companies 
  • October 17, 2011
    Fluidigm and Research Instruments Enter Distribution Deal for Singapore and Thailand
  • October 7, 2011
    Fluidigm Affirms 2011 Financial Outlook
  • October 3, 2011
    China's Rujin Hospital uses Fluidigm to Validate New Risk Loci for Graves' Disease 
  • September 12, 2011
    Fluidigm to participate in the Morgan Stanley Healthcare Conference
  • August 9, 2011
    Fluidigm Reports Financial Results for Second Quarter 2011
  • August 4, 2011
    Fluidigm Collaborates with BD Biosciences to Combine Cell Biology and Molecular Genetics for Single-Cell Research
  • July 14, 2011
    Fluidigm Announces Timing for Release of Q2, 2011 Financial Results and Extension of Lock-Up Agreements
  • July 6, 2011
    Fluidigm and Life Technologies Cross-License a Broad Set of Intellectual Properties
  • May 25, 2011
    Broad Institute Purchases Fluidigm Access Array™ System To Automate Sample Preparation For Targeted Resequencing
  • May 16, 2011
    Fluidigm Introduces Fast 192.24 Dynamic Array™ IFC for Genotyping
  • May 10, 2011
    Fluidigm Reports Financial Results for First Quarter 2011
  • May 9, 2011
    Fluidigm Launches Low-Cost Assays for Gene Expression, SNP Genotyping and Target-Specific Primers for Next-Generation Sequencing
  • May 5, 2011
    Fluidigm Delivers More Than One Billion Microscopic NanoFlex™ Valves
  • May 2, 2011
    Fluidigm to Announce Q1, 2011 Financial Results and Host Conference Call for Investors
  • April 4, 2011
    Fluidigm Adds Evan Jones to its Board of Directors
  • March 15, 2011
    Fluidigm Adds Patrick Jones to Its Board of Directors
  • March 9, 2011
    Fluidigm Reports Financial Results for the Fourth Quarter and Fiscal Year 2010
  • March 2, 2011
    Fluidigm to Present at Cowen and Company Annual Healthcare Conference
  • February 23, 2011
    Fluidigm and Eisenberg Brothers Ltd. Join Forces in Israel Distribution Deal
  • February 16, 2011
    IMGM Laboratories Utilizes Fluidigm Access Array™ System for Targeted Re-Sequencing Applications
  • February 16, 2011
    Fluidigm Corporation Announces Exercise of Underwriters' Over-Allotment Option
  • February 10, 2011
    Fluidigm Corporation Prices Initial Public Offering of Common Stock
  • February 1, 2011
    Fluidigm Introduces its Most Advanced Genomic Analysis System – The Biomark™ HD Real-Time PCR System

2010

  • December 3, 2010
    Fluidigm Files S-1 Registration Statement for Initial Public Offering
  • October 19, 2010
    Roche and Fluidigm Corporation Enter Worldwide Co-Promotion Agreement for 454 Sequencing Systems and Access Array™ Platform
  • September 13, 2010
    Fluidigm Introduces World's First Reusable Bio-Chip for SNP Genotyping
    Reusable FR48.48 Dynamic Array™ IFC can be used 5 times.
  • July 10, 2010
    Leading INRA Facility Reports Robust Genetic Analysis Results from Fluidigm Biomark™ System
    Number One Agricultural Institute in Europe Brings World-leading Integrated Fluidic Circuit Technology to All European Researchers.
  • June 30, 2010
    Fluidigm Technology Enables Stanford Researchers To Model Genetic Circuitry Of Cell-To-Cell Communication
    Dynamic Array™, Digital Array™ and Cell Culture IFCs Facilitate In-Depth Single-Cell Analysis
  • June 29, 2010
    Fred Walder Joins Fluidigm as Chief Business Officer
    Senior Executive from Fortune 500 Company to Lead Business Development and Marketing for Integrated Fluidic Circuit Inventor.
  • June 8, 2010
    Fluidigm Introduces World's First Reusable Bio-Chip Architecture
    Company Commits New Product Line to Support USDA Agricultural Research Service's "Penny-per-Data-Point" Program for High Sample Throughput Genotyping.
  • May 17, 2010
    Fluidigm Introduces New FC1™ Cycler that  cuts PCR Cycling Time by 3x
    The First of Several New Products Targeted to Boost Productivity while Lowering Costs for High Sample Throughput SNP Genotyping.
  • April 26, 2010
    Fluidigm Releases Access Array™ System Amplicon Tagging Protocol For Sequencing With 454 Gs Flx Titanium Series Reagents
  • April 20, 2010
    Singapore scientists' finding on early embryonic development has direct impact on regenerative medicine and assisted reproduction
  • March 24, 2010
    Fluidigm and QIAGEN's SABiosciences Team up to Provide Over 100 PCR Gene Expression Panels for BioMark Systems
  • March 16, 2010
    Leiden University Medical Center's Human Genetics Department Purchases a Fluidigm Access Array™ System
  • March 8, 2010
    Fluidigm Releases 5KB & 10KB Long Range PCR Protocol Access Array™ Systems
  • March 1, 2010
    Fluidigm Selected by MIT's Technology Review Magazine as one of the 50 Most Innovative Companies in the World
  • February 10, 2010
    Fluidigm Releases Access Array™ System Amplicon Tagging Protocol for Illumina GA II Users
  • January 27, 2010
    Fluidigm and Bayer Cropscience enter global agreement for marker-assisted breeding and quality control
    Multi-Year Supply Agreement to Drive High-Quality Seed Supply
  • January 25, 2010
    Fluidigm and Integragen join forces to create a genetic analysis service and european demonstration lab
  • January 7, 2010
    USDA'S Agricultural research service purchases Fluidigm solution for development and validation testing of cattle SNP panels
  • January 5, 2010
    OncoMed Pharmaceuticals, Inc. and Fluidigm Corporation Announce Strategic Collaboration
2009
  • December 14, 2009
    Fluidigm's BioMark™ System Sales Surpass the Century Mark
  • December 7, 2009
    Fluidigm Releases Access Array™ System for 454 FLX Amplicon Tagging
  • October 14, 2009
    Fluidigm and Nano Gen Teknolojileri Team Up in Turkish Distribution Deal
  • September 17, 2009
    Comprehensive Profiling of miRNAs in Stem Cells Using Microfluidics
  • September 14, 2009
    Fluidigm and Quimica Valaner Team Together in Mexican Distribution Deal
  • August 25, 2009
    Fluidigm: 250 Million Microfluidic Valves Manufactured - and Counting
    Singapore Factory the World's Largest Provider of Microfluidic Valves for Genetic Analysis.
  • June 24, 2009
    Kyoto University's CiRA (Director, Dr. Yamanaka) Purchases Fluidigm BioMark™ System for Stem Cell Reprogramming Research
    Single Cell Study Holds the Key to iPS Progress.
  • June 22, 2009
    Keio University's Dr. Suda Selects Fluidigm Biomark™ System for Single Cell Research
    Single Cell Study Holds the Key to Hematopoietic Stem Cell Progress.
  • June 16, 2009
    Fluidigm Introduces New Topaz® Protein Crystallization Chip that Provides a "Screen to Beam" Solution
    Protein Structures Can Provide Keys to Understanding and Preventing Diseases of Catastrophic Proportions.
  • June 15, 2009
    Fluidigm's New Access Array™ Chip Architecture Provides Superior Sample Prep for Next-Generation Sequencing
    Early Access Program Begins.
  • June 2, 2009
    Fluidigm and Uniscience Join Forces in Brazilian Distribution Deal
  • March 30, 2009
    Fluidigm Develops Absolute Quantification System that Allows Sequencing of Rare Samples
    DNA Quantification Also Eliminates Costly Preparation Steps for Next-Generation DNA Sequencing.
  • March 17, 2009
    Fluidigm and Chemoscience Technology Join Forces in Asia Distribution Deal
  • March 16, 2009
    Fluidigm's New Digital Array Delivers Peak Levels of Throughput for Digital PCR
    Provides Individual Molecule Quantification.
  • February 24, 2009
    Fluidigm Sells Record Numbers of Systems and IFC Chips in 2008
  • February 18, 2009
    Stanford University Uses Fluidigm Integrated Fluidic Circuits to Help Identify the Source of Cancer Stem Cell's Resistance to Radiation
  • February 2, 2009
    Cambridge University Research Group Employs Fluidigm's EP1 System for Cancer and Disease Association Studies
    EP1 System Delivers Enhanced Work Flow and Great Data Quality.
  • January 8, 2009
    Columbia River Inter-Tribal Fish Commission Uses Fluidigm IFC Technology for Genetic Analysis of Salmon and Steelhead
    EP1 System Delivers High Data Quality with Best-In-Class Workflow Efficiency.